Toshiba (TYO:6502) proposed the company keep interim CEO Masahi Muromachi on as permanent chief exec after 8 officials resigned due to their roles in an accounting scandal, Japanese media reports. Last week, Toshiba said former board chair Muromachi would temporarily take the reins as chief exec after an independent probe found former CEO Hisao Tanaka was aware […]
GlySure said today that it won CE Mark approval in the European Union for its continuous intravascular glucose monitoring system. The CIGMS device was cleared to monitor blood glucose among adult cardiac surgery patients in intensive care units, Abingdon, England-based GlySure said. In a clinical trial, the device met the primary safety and efficacy endpoints […]
Abbott (NYSE:ABT) said its board of directors approved the spinout of its branded pharmaceuticals business as AbbVie Inc. in which Abbott’s shareholders will receive an AbbVie share for each ABT share they own.
The distribution is slated for Jan. 1, 2013, for shareholders of record as of Dec. 12, according to a press release.
GlySure CEO Christopher Jones has a career spanning more than 2 decades and 2 continents, during which he’s seen the medtech regulatory pendulum swing from the Europe to the U.S. and back.
In an exclusive interview with MassDevice.com, Jones told us about being an American executive in the U.K., changing regulatory timelines and challenges to look for with a Europe-1st strategy.
MassDevice: You have a career that has spanned work with regulators in the U.S. and abroad. Tell us about your background.
Merck Global Health Innovation Fund will invest up to $17 million in medical app maker Physicians Interactive Holdings. The financing includes $8.5 million up front, but could double if the mHealth marketer meets Merck’s milestones.
The Marlborough, Mass.-based company plans to use the Merck funds to grow "4 key products," including its flagship medical resources app Skyscape.